Clinical trial
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC
NCT04476797
Study timeline
Study start (actual)2020-10-18Date precision: day
Registry last updated2024-04-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
GC4711 +SBRTDRUG
Placebo +SBRTDRUG
Sponsors & collaborators
Galera Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04476797 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.